(Q47990790)

7 February 2018

title

Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali. (English)

1 reference

7 February 2018

Plasmodium falciparum malaria

main subject

Mali

0 references

malaria

0 references

Plasmodium falciparum

0 references

vaccine

0 references

1 reference

1 reference

9

Ogobara K Doumbo

1 reference

7 February 2018

8

Christopher V Plowe

1 reference

7 February 2018

2

Alassane Dicko

1 reference

7 February 2018

Drissa Coulibaly

4

Drissa Coulibaly

1 reference

7 February 2018

Kirsten E Lyke

1

Kirsten E Lyke

1 reference

7 February 2018

Abdoulaye K Kone

3

Abdoulaye Kone

1 reference

7 February 2018

Yacouba Cissoko

6

Yacouba Cissoko

1 reference

7 February 2018

author name string

Ando Guindo

5

1 reference

7 February 2018

Karim Traoré

7

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 August 2004

1 reference

7 February 2018

published in

Vaccine

1 reference

7 February 2018

volume

22

1 reference

7 February 2018

issue

23-24

1 reference

7 February 2018

page(s)

3169-3174

1 reference

7 February 2018

A trial of the synthetic malaria vaccine SPf66 in Tanzania: rationale and design

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

Attributable fraction estimates and case definitions for malaria in endemic areas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

Is fever a good sign for clinical malaria in surveys of endemic communities?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

Clinical case definitions for malaria: Clinical malaria associated with very low parasite densities in african infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

Impact on malaria morbidity of a programme supplying insecticide treated nets in children aged under 2 years in Tanzania: community cross sectional study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

The effect of insecticide-treated bed nets on mortality of Gambian children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

A population-based clinical trial with the SPf66 synthetic Plasmodium falciparum malaria vaccine in Venezuela

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

Efficacy trial of malaria vaccine SPf66 in Gambian infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

Evaluation of SPf66 malaria vaccine efficacy in Brazil.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.054

10.1016/J.VACCINE.2004.01.054

7 January 2021

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

15297070

1 reference

7 February 2018